CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 4 Other disposition Director disposed of 827,467 shares (other)
- 4 Other acquisition Director acquired 11,017 shares (other)
- 4 Other disposition Director disposed of 827,467 shares (other)
- 4 Other acquisition 10% owner acquired 13,923 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 106,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Scientific Officer acquired 117,600 shares (grant or award)
- 4 Open-market buy 10% owner bought 6,458,904 shares at an average $11.01 ($71,088,067)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
Page 9 of 10 · 194 filings